Precigen, Inc. SEC filings PGEN

Precigen, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jan 26, 2016. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Precigen, Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 5, 2026 Nov 4, 2026
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
4 Insider transaction Sep 24, 2026 Sep 23, 2026
4 Insider transaction Aug 28, 2026 Aug 26, 2026
144 Notice of proposed sale Aug 26, 2026 —
4 Insider transaction Aug 25, 2026 Aug 21, 2026
4 Insider transaction Aug 25, 2026 Aug 23, 2026
4 Insider transaction Aug 25, 2026 Aug 23, 2026
4 Insider transaction Aug 25, 2026 Aug 21, 2026
4 Insider transaction Aug 25, 2026 Aug 23, 2026
4 Insider transaction Aug 25, 2026 Aug 23, 2026
144 Notice of proposed sale Aug 25, 2026 —
144 Notice of proposed sale Aug 25, 2026 —
144 Notice of proposed sale Aug 21, 2026 —
4 Insider transaction Aug 7, 2026 Aug 6, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 7, 2026 —
144 Notice of proposed sale Aug 6, 2026 —
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
4 Insider transaction Aug 3, 2026 Aug 3, 2026
144 Notice of proposed sale Aug 3, 2026 —
4 Insider transaction Jul 31, 2026 Jul 31, 2026
144 Notice of proposed sale Jul 31, 2026 —
4 Insider transaction Jul 1, 2026 Jun 29, 2026
4 Insider transaction Jul 1, 2026 Jun 29, 2026
4 Insider transaction Jul 1, 2026 Jun 29, 2026
144 Notice of proposed sale Jul 1, 2026 —
144 Notice of proposed sale Jun 29, 2026 —
144 Notice of proposed sale Jun 29, 2026 —
144 Notice of proposed sale Jun 29, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 24, 2026 Jun 18, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction May 27, 2026 May 23, 2026
4 Insider transaction May 27, 2026 May 23, 2026
4 Insider transaction May 27, 2026 May 23, 2026
4 Insider transaction May 27, 2026 May 23, 2026
4 Insider transaction May 27, 2026 May 23, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Jun 18, 2026
4 Insider transaction Apr 22, 2026 Apr 20, 2026
4 Insider transaction Apr 22, 2026 Apr 20, 2026
4 Insider transaction Apr 22, 2026 Apr 20, 2026
4 Insider transaction Apr 22, 2026 Apr 20, 2026
4 Insider transaction Apr 22, 2026 Apr 20, 2026
4 Insider transaction Mar 31, 2026 Mar 26, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 31, 2026 —
144 Notice of proposed sale Mar 30, 2026 —
10-K Annual report Mar 25, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 25, 2026 Mar 25, 2026
4 Insider transaction Mar 20, 2026 Mar 18, 2026
4 Insider transaction Mar 20, 2026 Mar 18, 2026
4 Insider transaction Mar 20, 2026 Mar 18, 2026
4 Insider transaction Mar 20, 2026 Mar 18, 2026
4 Insider transaction Mar 20, 2026 Mar 18, 2026
4 Insider transaction Mar 16, 2026 Mar 13, 2026
4 Insider transaction Mar 16, 2026 Mar 13, 2026
4 Insider transaction Mar 16, 2026 Mar 13, 2026
4 Insider transaction Mar 16, 2026 Mar 13, 2026
4 Insider transaction Mar 16, 2026 Mar 13, 2026
4 Insider transaction Mar 16, 2026 Mar 13, 2026
4 Insider transaction Mar 16, 2026 Mar 13, 2026
4 Insider transaction Mar 16, 2026 Mar 13, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
UPLOAD Letter from the SEC Mar 5, 2026 —
CORRESP Letter to the SEC Feb 23, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
UPLOAD Letter from the SEC Feb 10, 2026 —
CORRESP Letter to the SEC Jan 29, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jan 23, 2026 —
UPLOAD Letter from the SEC Dec 23, 2025 —
4 Insider transaction Dec 22, 2025 Dec 22, 2025
144 Notice of proposed sale Dec 22, 2025 —
4 Insider transaction Dec 16, 2025 Dec 12, 2025
144 Notice of proposed sale Dec 12, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 21, 2025 —
4 Insider transaction Nov 21, 2025 Nov 19, 2025
144 Notice of proposed sale Nov 20, 2025 —
144/A Filing Nov 20, 2025 —
144 Notice of proposed sale Nov 19, 2025 —
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 30, 2025 —
4 Insider transaction Oct 1, 2025 Sep 29, 2025
4 Insider transaction Sep 30, 2025 Sep 30, 2025
144 Notice of proposed sale Sep 30, 2025 —
144 Notice of proposed sale Sep 30, 2025 —
4 Insider transaction Sep 30, 2025 Sep 26, 2025
4 Insider transaction Sep 30, 2025 Sep 29, 2025
144 Notice of proposed sale Sep 29, 2025 —
4 Insider transaction Sep 26, 2025 Sep 25, 2025
SCHEDULE 13G Ownership over 5% (passive) Sep 23, 2025 —
EFFECT Filing Sep 19, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 19, 2025 —
4 Insider transaction Sep 19, 2025 Sep 17, 2025
144 Notice of proposed sale Sep 19, 2025 —
144 Notice of proposed sale Sep 18, 2025 —
CORRESP Letter to the SEC Sep 17, 2025 —
8-K Current report
Unregistered share sale
Sep 17, 2025 Sep 15, 2025
4 Insider transaction Sep 16, 2025 Sep 12, 2025
4 Insider transaction Sep 16, 2025 Sep 12, 2025
4 Insider transaction Sep 16, 2025 Sep 12, 2025
4 Insider transaction Sep 16, 2025 Sep 12, 2025
4 Insider transaction Sep 16, 2025 Sep 12, 2025
4 Insider transaction Sep 5, 2025 Sep 4, 2025
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Sep 3, 2025 Sep 3, 2025
4 Insider transaction Aug 29, 2025 Aug 19, 2025
UPLOAD Letter from the SEC Aug 26, 2025 —
S-3 Shelf registration Aug 19, 2025 —
8-K Current report
Material agreement
Aug 18, 2025 Aug 13, 2025
8-K Current report
Regulation FD disclosure
Aug 18, 2025 Aug 18, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
4 Insider transaction Jul 7, 2025 Jul 5, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 30, 2025 Jun 26, 2025
4 Insider transaction Jun 27, 2025 Jun 26, 2025
4 Insider transaction Jun 27, 2025 Jun 26, 2025
4 Insider transaction Jun 27, 2025 Jun 26, 2025
4 Insider transaction Jun 27, 2025 Jun 26, 2025
4 Insider transaction Jun 27, 2025 Jun 26, 2025
4 Insider transaction May 27, 2025 May 23, 2025
4 Insider transaction May 27, 2025 May 23, 2025
4 Insider transaction May 27, 2025 May 23, 2025
4 Insider transaction May 27, 2025 May 23, 2025
4 Insider transaction May 27, 2025 May 23, 2025
4 Insider transaction May 16, 2025 May 16, 2025
4 Insider transaction May 16, 2025 May 16, 2025
4 Insider transaction May 16, 2025 May 16, 2025
4 Insider transaction May 16, 2025 May 16, 2025
4 Insider transaction May 16, 2025 May 16, 2025
ARS Annual report to shareholders May 16, 2025 Dec 31, 2024
DEFA14A Additional proxy material May 16, 2025 —
DEF 14A Proxy statement May 16, 2025 Jun 26, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
PRE 14A Preliminary proxy statement May 6, 2025 Jun 26, 2025
10-K/A Amended annual report Apr 28, 2025 Dec 31, 2024
4 Insider transaction Apr 18, 2025 Apr 17, 2025
4 Insider transaction Apr 18, 2025 Apr 17, 2025
4 Insider transaction Apr 18, 2025 Apr 17, 2025
4 Insider transaction Apr 18, 2025 Apr 17, 2025
4 Insider transaction Apr 18, 2025 Apr 17, 2025
10-K Annual report Mar 19, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 19, 2025 Mar 19, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
4 Insider transaction Feb 3, 2025 Jan 29, 2025
4 Insider transaction Feb 3, 2025 Jan 29, 2025
4 Insider transaction Feb 3, 2025 Jan 29, 2025
4 Insider transaction Feb 3, 2025 Jan 29, 2025
4 Insider transaction Feb 3, 2025 Jan 29, 2025
8-K Current report
Other events
Jan 16, 2025 Jan 16, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 30, 2024 —
4 Insider transaction Dec 30, 2024 Dec 30, 2024
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure, Other events
Dec 30, 2024 Dec 27, 2024
8-K Current report
Material agreement
Dec 26, 2024 Dec 18, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
8-K Current report
Listing notice
Nov 7, 2024 Nov 1, 2024
8-K Current report
Agreement ended
Oct 10, 2024 Oct 4, 2024
8-K Current report
Officer or director change
Sep 23, 2024 Sep 20, 2024
8-K Current report
Officer or director change
Aug 30, 2024 Aug 28, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
4 Insider transaction Aug 13, 2024 Aug 9, 2024
4 Insider transaction Aug 13, 2024 Aug 9, 2024
SC 13D/A Amended ownership over 5% (active) Aug 13, 2024 —
8-K Current report
Material agreement
Aug 9, 2024 Aug 7, 2024
424B5 Prospectus supplement Aug 8, 2024 —
424B5 Prospectus supplement Aug 6, 2024 —
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Aug 6, 2024 Aug 6, 2024
4 Insider transaction Jul 24, 2024 Jul 22, 2024
3 Initial insider ownership Jul 24, 2024 Jul 22, 2024
4 Insider transaction Jul 9, 2024 Jul 5, 2024
3 Initial insider ownership Jul 9, 2024 Jul 5, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jul 5, 2024 Jul 5, 2024
4 Insider transaction May 31, 2024 May 31, 2024
4 Insider transaction May 31, 2024 May 31, 2024
4 Insider transaction May 31, 2024 May 31, 2024
4 Insider transaction May 31, 2024 May 31, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PGEN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
VA
Headquarters
Germantown, MD
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1356090
Former names
INTREXON CORP (until Jan 22, 2020)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.